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ABSTRACT 
PIasmodi urn know!es 1 cell line was maintained and 
allowed to multiply, in vivo, in Rhesus monkeys. Daily blood 
films were made to observe the appearance of parasites in the 
peripheral blood. The parasitaemia reached to about 80^ on 
the 12th day of infection. 
The parasites were isolated through the use of numerous 
centrifugations, washings and lysis of the erythrocytes by 
the use of saponin. The free parasites were disrupted by 
ultrasonication and the suspension was centrifuged again to 
obtain the antigen. 
Blood films and sera specimens were taken from 50 
patients with clinically diagnosed malaria from the J.N.M.C. 
Hospital Out Patient Department and from those who were 
admitted to the J.N. Medical College Hospital wards, Aligarh, 
India. 
The blood films were stained by Leishman stain and 
observed under the microscope for the presence of malaria 
parasites. Indirect haemagglutination tests were done on the 
sera samples to determine malaria parasite specific antibody 
titres against P. knowlesi antigen. 
VI1 
The parasitologic examination of slides yielded 21 
(42%) blood films positive for malaria parasite and 29 (58%) 
negative blood films. The sera of patients with positive 
blood films gave a positive antibody titre (_>1:16) in &)% 
cases, while the sera from patients with negative blood films 
were about 73* IHA positive. 
26 control patients were also included in the study 
(that is those with no clinical evidence of malaria and 
showing a negative blood film) from whom blood films and sera 
specimens were taken. Only 1 (4%) serum sample gave a 
positive titre in the above control groups. 
INTRODUCTION 
Malaria is a communicable disease caused by Sporozoon 
parasites of the genus Plasmodium and transmitted to man by 
certain species of infected female Anopheline mosquitoes. 
The disease is characterised clinically by 3 stages. 
(a) Cold stage: sudden onset of fever with rigor and 
sensation of extreme cold accompanied by shivering. 
(b) Hot stage: patient feels burning hot and casts off 
all his clothes, there is intense headache. 
(c) Sweating stage: fever comes down with profuse 
sweating. There is enlargement of spleen and 
secondary anaemia with a tendency to relapses (WHO, 
1986) . 
Malaria is a threat to almost half the world's 
population. It is a major health problem in tropical 
countries, where approximately three hundred million cases 
occur annually. In Africa alone, almost one to two million 
children die of the disease every year (Siddiqui, 1991). In 
India an alarming increase in malaria cases has been 
reported since 1965 and the maximum number has been 
recorded in 1976 (6.5 x 10^) (Ghatak ^^ al-, 1987). The 
number of confirmed cases recorded in 1988 were 1.78 
million (WHO, 1990). 
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HISTORICAL REVIEW 
Malaria is caused by a protozoan parasite of the 
genus Plasmodium. The first accurate clinical descriptions 
of malarial fevers were given by Hippocrates in 400 B.C.; 
(Boyd, 1949) who mentioned the classic triad of chills, 
fever and sweating. It seems that malarial fevers were 
also known in ancient China and that Arab physicians during 
the eight to the thirteenth century were commonly 
acquainted with intermittent fevers (Boyd, 1949). 
The first treatment of malaria came in the middle of 
the seventeenth century with the introduction of the bark 
of a Peruvian tree which was subsequently called cinchona. 
Pelletier and Caventon, in 1820, succeeded in extracting 
quinine from cinchona which was found to have an 
antimalarial effect (Scott, 1939). 
Meckel, in 1847, showed black granules, embedded in 
protoplasmic masses, in the blood of patients suffering 
from malaria. In 1880, Laveran, a French Army surgeon 
discovered the malaria parasite in Algiers, North Africa. 
In 1891, Romanowsky in Russia developed a new method of 
staining blood films which made possible complete studies 
of the malaria parasite. It was proved by Gerhardt (1884) 
that malaria could be induced in healthy persons by 
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inoculation of blood of severely ill malarious patients. 
Manson (1894) hypothesised that mosquitoes transmitted 
malaria and Ronald Ross (1897) found malaria parasite of 
man, growing as cysts (oocysts) on the stomach wall of an 
Anopheline mosquito which had previously fed on a malaria 
patient. 
CLASSIFICATION 
There is still a lot of discussion and uncertainty 
about the classification of malaria parasites. The 
classification of the phylum protozoa introduced by the 
society of Protozoo1ogists (Honigberg gjfc. al- , 1964) 
provides a generally accepted system based on morphological 
and biological criteria, as well as on phylogenetic 
considerations. According to this classification, the 
malaria parasites belong to the subphylum Sporozoa, class 
Telesporea and subclass Coccidia. 
All members of the Subphylum Sporozoa are parasitic 
of which some produce resistant spores or have a stage in 
their life cycle which is derived from a resistant spore; 
these forms contain one or more sporozoites. All 
Telosporea possess sporozoites and reproduce sexually. The 
common characteristic of subclass Coccidia is the 
intracellular nature of the trophozoites. 
MALARIA LIFE CYCLE 
More than 100 plasmodial species have been described, 
causing malaria in a wide range of vertebrates and 
exhibiting narrowly defined host specificity. Four species 
infect man, P. falciparum. £. vivax. P, malaniafi, and P. 
ovale, the first being the most lethal. P. vivax has the 
widest distribution throughout the world. In India, 65 to 
69 per cent of the infections are reported to be due to P. 
vivax. 25 to 30 per cent due to P. falciparum and 4 to 8 
per cent due to mixed infections. P. malariae is said to be 
responsible for less than one per cent of infections in 
India (Park and Park, 1386). 
The malaria parasite undergoes two cycles of 
development, the human or asexual cycle and the mosquito or 
the sexual cycle. Man is the intermediate host and mosquito 
the definitive host. 
Asexual Cycle: The asexual cycle begins when an infected 
mosquito bites a person and injects sporozoites. Four 
phases are described in the human cycle. 
(a) Pre-erythrocytic phase: The sporozoites disappear with 
half an hour from peripheral circulation and reach the 
liver cells, where they undergo a cycle of development 
which lasts for 6 to 8 days. At the termination of this 
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phase a shower of parasites (cryptozoites) are liberated 
into the blood circulation (Garnham, 1966; Ayala, 1977). 
(b) Erythrocytic Phase: The parasite passes through the 
stages of trophozoite and schizont. The phase ends with 
the liberation of merozoites which infect fresh red cells. 
This release of merozoites into the blood stream causes 
fever, the prime symptom of malaria. 
(c) Gametogony: Some of the merozoites penetrate the red 
cells but instead of developing into schizonts, they become 
gametocytes. These are the sexual forms of the parasite 
which are infective to mosquito (Aikawa gj;: ,aJ.. , 1978). 
(d) Exoerythrocyti c Phase: In £. f_aJJLiP_aJliLDl the 
intrahepatic schizonts rupture almost simultaneously and 
there is no persistent tissue phase. The intrahepatic 
schizonts of other Plasmodia do not burst all at the same 
time and may remain dormant for an indeterminate period. 
The cycle remains potentially active for 1 to 3 years for 
£• vi vax and P. ovale. In P. malari ae recurrences are 
possible 10, 2 0 and even 40 years after sporozoite 
inoculation. The exoerythrocytic cycle is sustained 
exclusively by blood schizogony or released from liver, 
cells are not capable of reinfecting the liver (Park and 
Park, 1986). 
Sexual Cycle: The sexual cycle or sporogony is initiated 
when an Anopheline mosquito capable of transmitting malaria 
feeds on a malaria patient. In the lumen of the midgut, 
the gametocytes escape from the host cells and soon undergo 
changes preparatory to fertilization. The male gametocyte 
(microgametocyte) through a process known as 
"exf1agellation" form a number of sperm-like bodies. 
Fertilization occurs when a microgamete- enters a 
macrogamete by chemotaxis and a zygote is formed. The 
motile zygote or ookinate penetrates the stomach wall of 
the mosquito and after about 24 hours develops into an 
oocyst on the outer surface of the stomach (Sinden, 1975; 
Speer £i M-, 1975). The oocyst grows rapidly and develops 
within its numerous sporozoites. The oocyst ruptures into 
the body cavity after about 2 weeks and many of the 
sporozoites eventually find their way into the salivary 
glands of the mosquito which now become infective to man 
(Joklik fii al., 1984). 
IMMUNITY TO MALARIA 
Innate resistance influences the pattern of acquired 
malarial immunity which differs widely in distinct host-
parasite combinations and even with the same parasite in 
closely related host species. The mechanisms of innate 
resistance has been shown to influence the development of 
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a l l asexual blood forms but none of those res is tances seem 
to act upon gametocytes ( M i l l e r and Car te r , 1976). 
I n d i v i d u a l s t h a t lack the Duffy b lood-group ant igens 
on t h e i r e r y th rocy tes are r e s i s t a n t t o P. v ivax i n f e c t i o n , 
because the receptor f o r the P. v ivax merozoi tes on the red 
c e l l i s assoc ia ted w i t h ant igens of the Duffy blood group 
(Butcher ^ a l - , 1973; M i l l e r e i a l . , 1973, 1978; Barnwell 
e t a l . • 1 9 8 9 ) . T h i s e x p l a i n s t h e l o n g r e c o g n i s e d 
res is tance t o P. v ivax i n f e c t i o n of West A f r i c a n blacks and 
t h e i r descendants i n the USA. Because these popu la t ions 
have a h igh f requency o f the D u f f y n e g a t i v e genotype 
( M i l l e r e i a_L- , 1 9 7 6 ) . H e t e r o z y g o t e s f o r 
haemoglobinopathies and other d i so rders of the red c e l l s 
( t h a l a s s e m i a and g 1 u c o s e - 6 - p h o s p h a t e d e h y d r o g e n a s e 
d e f i c i e n c y ) promote i n n a t e r e s i s t a n c e t o P.. f a l e i oarum 
i n f e c t i o n (Wea the ra l l , 1987). Such p r o t e c t i o n i s probably 
t r i gge red by m o d i f i c a t i o n s of p a r a s i t e development w i t h i n 
the e r y t h r o c y t e s o f these i n d i v i d u a l s . However, i t has 
been proposed t h a t these simple p h y s i o l o g i c a l e f f e c t s may 
f o s t e r p r o c e s s e s t h a t l e a d t o an enhancement i n t h e 
i n t e n s i t y a n d / o r s p e c i f i c i t y o f t h e a d a p t i v e immune 
response, e n a b l i n g i n d i v i d u a l s c a r r y i n g t h e s e genes t o 
acqu i r e c l i n i c a l immunity t o m a l a r i a f a s t e r t h a n o t h e r s 
( A l l i s o n , 1984 , B a y o u m i , 1 9 8 7 ) . I n s u p p o r t o f t h i s 
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hypothesis Bayoumi sX. al (1990) found that lymphocytes of 
individuals carrying the HbAS genotype showed higher 
reactivity to malaria antigens in proliferative assay than 
lymphocytes from HbAA controls living in the same area. 
Protection to malaria, acquired by individuals living 
in endemic areas is largely governed by the transmission 
pattern. MacDonald (1957) identified two epidemiological 
extremes in which the disease exists, one where instability 
of transmission is the dominant feature and the disease is 
characterized by substantial seasonal fluctuations, 
producing cyclical epidemics in the entire population 
regardless of age. In the other case, transmission and 
morbidity remain stable over the seasons and years, with 
the population exposed to frequent heavy inoculations. The 
individuals appear to acquire protection against clinical 
attacks after several years (Theander, 1992) and the 
disease therefore affects mainly children. 
McGregor (1960) proposed that individuals living in 
areas with stable malaria pass through five stages before 
immunity is acquired. In stage one (age group 0-2 months) 
infants are protected against malaria and parasites are 
only found in the peripheral blood of approximately 10* 
(Gilles, 1961). 
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During stage two (2-6 months) parasites are found 
more frequently in the blood (Gilles, 1961) and the 
children often experience the first mild clinical attack of 
malaria. 
Stage three (7 months-2 years) is characterized by 
repeated attacks of malaria which are associated with 
severe illness. Parasites are almost always found in the 
peripheral blood in high densities. Malaria disrupts the 
normal pattern of growth in this age, producing severe 
anaemia and high mortality rate (McGregor gi aJ_. , 1956). 
Stage four (3-4 years) represents the acquisition of 
the first phase of clinical immunity characterized by a 
rapid decline in the severity and.frequency of clinical 
episodes, despite the persistence of a relatively dense 
parasitaemia. 
In the fifth stage clinical malaria attacks are rare 
and mild. Adults living in the area often harbour the 
parasite without clinical symptoms. Reports by Colbourne 
(1955) on susceptibility to malaria in students returning 
to Africa after studies in Europe, and by Mastbaum and 
Goeckel (as quoted by Bruce-Chawatt, 1963) on malaria 
outbreaks suggest that immunity diminishes in individuals 
living in areas free of transmission. Whether this is due 
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t o i n t r o d u c t i o n of new p a r a s i t e s t r a i n s when exposure was 
r e s t o r e d or due t o lack o f i m m u n o l o g i c a l memory i s no t 
known. 
Thus i n d i v i d u a l s l i v i n g in areas of s t ab l e malar ia 
t ransmiss ion develop p r o t e c t i o n to the devas ta t ing e f f e c t s 
of the d isease over a number o f y e a r s . Such p r o t e c t e d 
i n d i v i d u a l s are c h a r a c t e r i z e d by t h e r a r i t y o f c l i n i c a l 
symptoms and t h e i r mi ldness i f an a t tack of ma la r ia occurs . 
Acquired immunity i s on ly p a r t i a l , as pa ras i t es are found 
i n low d e n s i t y i n t h e p e r i p h e r a l b l o o d o f p r o t e c t e d 
i n d i v i d u a l s and immunity wanes once t h e exposu re t o t h e 
pa ras i t e ceases. 
Defence mechanisms o f immun i ty a re med ia ted and 
regu la ted through an i n t e r p l a y between d i f f e r e n t pa r ts of 
the system. The c l a s s i c a l d i v i s i o n i n t o the s p e c i f i c and 
non -spec i f i c pa r ts of the system and between B and T - c e l l 
m e d i a t e d i m m u n i t y becomes l e s s d i s t i n c t when i t i s 
understood t h a t T - c e l l s f o r instance s t i m u l a t e non -spec i f i c 
N a t u r a l K i l l e r (NK) c e l l s and m o n o c y t e s t h r o u g h t h e 
s e c r e t i o n o f I n t e r l e u k i n -2 - f I L - 2 ) and i n t e r f eron- lJ 
( IFN->^ ). T - c e l l s are on l y a c t i v a t e d when exposed t o 
a n t i g e n by a n t i g e n p r e s e n t i n g c e l l s . The e f f e c t o f 
an t ibod ies are o f t en t o opsonize micro-organisms so t ha t 
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they are easily phagocytized, the T-cells regulate the 
production of antibodies by B-cells. (Theander, 1992). 
The premise that macrophages, or their products are 
important for protection is supported by experiments in 
which mice were protected against sporozoite-induced 
(Nussenzweig, 1967) or blood-stage induced malaria 
infections CClark ei al., 1976, 1977) by non-specific 
stimulation of the phagocytic defence systems through the 
administration of BCG. Cells of the macrophage lineage and 
neutrophils are also able to kill liver stages of the 
parasites and have been shown to infiltrate liver tissue 
and destroy rat hepatocytes infected with P. berqhei (Meis 
gLl a,I. , 1987). 
Monocytes or macrophages eliminate malaria parasites 
both by phagocytosis and through secretion of molecules 
toxic to the parasite. Peripheral blood monocytes from 
malaria unsensitized donors are able to attach to and 
ingest P. falciparjum merozoites. Phagocytosis is markedly 
enhanced in the presence of immune serum (Krusmith and 
Druilhe, 1983). Results obtained in a mouse model indicate 
that non-activated macrophages primarily bind Plasmodia via 
receptors for carbohydrate containing glycoproteins, while 
activated macrophages bind them via Fc receptors (Brown and 
Kreier, 1986). Phagocytosis seems to be regulated by the 
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T-cells as Plasmodium antinen-stimu1ated T-cel1s from 
spleens of malaria infected mice produced a lymphokine 
capable of activating macrophages for enhanced Fc-receptor 
mediated phagocytosis (Ockenhouse and Shear, 1983). Malaria 
parasites trigger macrophages to release parasite toxic 
mediators and the activity is regulated by T-cells 
(Ockenhouse and Shear. 1984). 
Macrophages play an important role as antigen 
presenting cells. T-cell receptors co-recognize complexes 
of antigen and products of major histocompatibility complex 
(MHO on the surface of other cells. Subpopulations of 
antigen presenting cells handle antigens differently, and 
the way monocytes process and present antigens play a role 
in activation of subpopulations of T-cells, whereby they 
influence the outcome of the activation process (Theander. 
1992). 
Besides their role in protection, the macrophages 
appear to play a role in the pathogenesis of the disease. 
Malaria antigen can stimulate tumour necrosis factory: 
(TNF- oC ) and IL-1 production in macrophages (Jakobsen e_t 
al-, 1990), although these can induce anti-parasitic 
effects. They probably also contribute to the symptoms arid 
complications of malaria (Clark ejt a±. . 1989). Both 
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monokines can induce fever and they seem to play a critical 
role in the pathogenesis of cerebral malaria (Grau et al.. 
1987). 
Neutrophils can inhibit the growth of P. falciparum 
in vitro (Brown and Smalley, 1981; Nnalue and Friedman, 
1988). They probably kill the parasite and have been shown 
to phagocytize parasitized erythrocytes j_n vivo (Kharazmi 
e.t al. , 1987 ) and in vitro (Celada et al- . 1983). 
Little is known about the role of eosinophils in the 
protection against malaria as the infection does not result 
in eosinophi1ia. The in vitro growth of P. falciparum can 
be inhibited by granule proteins secreted by purified 
eosinophils. Both the eosinophil cationic protein and 
other granule products seem to be toxic to parasites as 
monoclonal antibody against the cationic protein only 
partially blocked the inhibitory effect (Waters et a].. 
1987) . 
T-cells might participate in the protection against 
malaria as (1) helper cells for antibody production, (2) 
through the activation of non-specific effector cells like 
macrophages or granulocytes, (3) through the production of 
substances toxic to the parasites and (4) as cytotoxic 
cells (Theander, 1992). 
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A l t h o u g h T and B - c e l l s can c o n v e y some i m m u n i t y , 
o p t i m a l p r o t e c t i o n i s o b t a i n e d by t h e t r a n s f e r o f T - c e l l s 
o f t h e Ly-1 pheno type , i n c o m b i n a t i o n w i t h B - c e l l s . 
A l t h o u g h T and B - c e l l s can c o n v e y some i m m u n i t y 
o p t i m a l p r o t e c t i o n i s o b t a i n e d by t h e t r a n s f e r o f T - c e l l s 
o f t h e L y - I pheno type , i n c o m b i n a t i o n w i t h B - c e l l s . 
However, T - c e l l s a re a l s o ab le t o convey immuni ty i n 
a n t i b o d y i n d e p e n d e n t s y s t e m s . B - c e l l d e f i c i e n t m i c e 
t e r m i n a t e t h e i r i n f e c t i o n i n t h e same way as 
i m m u n o l o g i c a l l y i n t a c t m i c e , t h e p r o t e c t i o n depends on the 
presence o f an i n t a c t s p l e e n (Grun et al. , 1985) . T - c e l l s 
m i g h t a l s o p l a y a r o l e i n p r e v e n t i n g t r a n s m i s s i o n o f 
m a l a r i a as H a r t e e i a j_ . ( 1 9 8 5 ) w e r e a b l e t o r e d u c e 
t r a n s m i s s i o n by 95% by p a s s i v e t r a n s f e r o f T - c e l l s f r o m 
immune t o u n p r o t e c t e d a n i m a l s . 
S e r o - e p i d e m i o l o g i c a l s t u d i e s o f t o t a l m a l a r i a 
s p e c i f i c a n t i b o d i e s have i n d i c a t e d t h a t t h e r e i s an age 
dependent i n c r e a s e i n a n t i b o d y l e v e l s i n i n d i v i d u a l s l i v i n g 
i n m a l a r i a endemic a r e a s ; t h e l e v e l o f t hese a n t i b o d i e s i s 
not an index o f f u n c t i o n m a l a r i a immun i t y , bu t an i n d i c a t o r 
o f t h e d e g r e e o f m a l a r i a e x p o s u r e i n t h e p o p u l a t i o n 
( V o l l e r , 1 9 7 1 ) . The a n t i b o d i e s a r e d i r e c t e d a g a i n s t 
s p o r o z o i t e ( N a r d i n e t a l . , 1979) as w e l l as b lood s tage 
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(Cohen and Butcher. 1971) and gametocyte (Mendis et a1.. 
1987) antigens. 
Complement does not seem to be able to kill parasites 
directly, but could play a role as an opsonin for 
neutrophils and macrophages (Salmon gt al., 1986). 
The acquisition of immunity is a slow process during 
which the individual is exposed to the parasite on numerous 
occasions. The parasite could (1) prevent or divert the 
immune recognition and (2) inhibit the immune responses to 
antigens that have, or could be recognized by the immune 
system. During blood stage infections, the parasite is 
mostly intracellular and exposed to the extracellular 
environment only for short periods of time before it 
invades a new host cell. The parasite is partly hidden 
from the immune system. The erythrocytes infected with 
late trophozoites and schizonts bind to the endothelial 
cells of the capillary system, thus avoiding the effector 
cells of the spleen and other tissues. 
More than twenty P. f alci parum proteins have been 
shown to share amino acid sequences with human proteins 
(McLaughlin gt al., 1987). The blood stage antigen Pf 11.1 
shows homology with a thymic peptide (Dubois et al., 1988). 
a gametic stage antigen contains segments homologous with 
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epidermal growth f a c t o r (Kaslow et_ a j . . , 1988) and the 
cen t ra l repeat segment of the c i rcumsporozo i te p r o t e i n is 
homologous w i t h a m i tochondr ia l p r o t e i n (McLaughlin e t a l . , 
1987). The e f f e c t of these homo log ies m i g h t be t h a t 
o the rw ise immunogenic segments o f m a l a r i a p r o t e i n s are 
recognized as ' S e l f and t o l e r a t e d by the immune system. 
Paras i tes have been repor ted to cross the p lacenta and gain 
access t o the f e t a l c i r c u l a t i o n b e f o r e and d u r i n g b i r t h 
(Reinhardt e t al. , 1978). Although these c h i l d r e n seldom 
develop c l i n i c a l ma lar ia (McGregor, 1984), to le rance might 
be induced f o l l o w i n g the prenata l or p e r i n a t a l exposure to 
malar ia ant igens (Pombo e t aj_-, 1988). 
The pa ras i t es appear t o be able to undergo an t igen ic 
v a r i a t i o n w i t h i n a s i n g l e c l o n e and exp ress a l t e r n a t i v e 
forms of a molecule from a given genie r e p e r t o i r e (Hommel 
e t al . . 1983, Fenton ejt a j_- , 1985 ) . Such d i v e r s i t y i n 
m a l a r i a p a r a s i t e s i s l i k e l y t o c o n t r i b u t e t o the s low 
development of immuni ty . Many m a l a r i a p r o t e i n s c o n t a i n 
shor t amino ac id sequences t h a t are ex tens i ve l y repeated in 
tandem a r r a y s . These r e p e a t e d sequences encode 
immunodominant e p i t o p e s t o wh ich much o f t he a n t i b o d y 
response a g a i n s t the p a r a s i t e i s d i r e c t e d (Kemp eX. a l . , 
1987). An t ibod ies aga ins t one such ep i tope o f t en c ross-
react w i t h o ther repeated ep i topes , e i t h e r w i t h i n the same 
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molecule or on other parasite proteins. Anders (1986) 
proposed that these cross-reactions interfere with the 
maturation of hiqn affinity antibody directed against the 
parasi te. 
Acute malaria infection causes marked perturbations 
in the immune system of the host. On one hand, the 
infection induces a powerful polyclonal activation of the 
immune system resulting in hyper-gamma globulinaemia and 
production of auto-antibodies, and on the other hand the 
infection results in a depression of immune reactivity. 
Symptoms and signs of respiratory and gastrointestinal 
infections are common in children with acute malaria, but 
this may be attributed directly to the parasite (Greenwood 
ejt a.!., 1989). Clinical reports have indicated that 
Salmonella infections are especially severe in malarious 
children (Bennett and Hook, 1959). Although clinical 
evidence for immuno suppression during malaria is not 
overwhelming, results of these studies on P.. falciparum 
malaria plus convincing evidence showing immunosuppression 
during malaria in animals has led to a series of studies in 
which immune reactivity during P. falciparum malaria was 
characterized jm vi tro (Weidanz, ^962]. 
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MALARIA VACCINES 
Accordinq to WHO, about 100 million people are 
clinically ill with malaria at any given time, and around 1 
million - mostly very young children in Africa - die from 
it each year. The effects are so widespread in the tropics 
- ranging from lethargy to total incapacitation - that 
malaria has been blamed for impeding the development of 
entire nations and the problems with malaria will be 
getting worse in the years ahead. 
The main strategy for fighting malaria through the 
1960s was to use pesticides to kill mosquitoes that carry 
the parasite and to treat infected individuals with quinine 
- related drugs, mainly chloroquine. However, the most 
lethal strain of the parasite, P.. falciparum is now 
genetically resistant to chloroquine. Health authorities 
are switching to a new compound, mefloquine, but already 
there are signs in Asia and Africa that the parasite is 
resistant to this as well. It is only a matter of time 
before the resistance spreads (Cherfas, 1990). 
Malaria vaccines will be based on pure parasite 
antigens which specifically stimulate protective immune 
responses. Protective antigens are present in several of 
the developmental forms of the parasite and future vaccines 
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may contain antigens from one or more of these, at present 
most of the relevant research concerns P.. f a1 c i parum. 
Vaccine trials currently envisaged are: (i) Sporozoites, 
(ii) asexual erythrocytic stage, and (iii) gametes and 
other forms developing in the mosquito midgut (WHO, 1986). 
S-antigens of P. falci parum have also been successfully 
employed for vaccination experiments (Ristic et al., 1985). 
Vaccination of rodents, monkeys, birds and humans 
with X-irradiated sporozoites induces protective immunity 
to subsequent challenge with living sporozoites (Strickland 
and Nussenzweig, 1982). Preliminary attempts at sporozoite 
vaccination were made in 1971 - 1975 using X-irradiated 
sporozoites of P. f al ci parum and P_. v i v a x which were 
innoculated by mosquito bites into previously non-exposed 
human volunteers. This bold trial brought to light the 
information that the immunity to the Sporozoite challenge 
became detectable 7-10 days after innoculation, immunity 
was species and stage specific and appeared after 10 days 
of immunization and persisted for 3-5 months and, no side 
effects to the vaccine were observed (WHO, 1986). The most 
promising achievement with regard to the development of a 
sporozoite vaccine was gene cloning of P. knowlesi antinens 
in Escherichi a coli. This was done by extracting the 
messenger RNA encoding circumsporozoite protein from 
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infected mosquitoes through conversion, by enzyme reverse 
transcriptase, into CDNA. The fragments of CDNA were 
inserted into bacterial plasmids which were in turn 
introduced into £. coli. The bacterial clones excreted 
peptides binding to the monoclonal antibodies and against 
circumsporozoite protein of P. knowlesi (Sharma and Godson, 
1985) . 
Sequencing analysis of circumsporozoite protein 
showed that the immunodominant antigenic determinant 
(epitope) contains a sequence of 12 amino acids and the 
peptides share common antigens with the original 
circumsporozoite protein (WHO, 1985). 
A sporozoite vaccine, if fully effective, would 
prevent the establishment of plasmodial development in the 
host and thus induce sterile immunity. Parasitaemia, 
asexual or sexual, would therefore not occur; clinical 
illness would not supervene and the subject would remain 
incapable of infecting mosquitoes. A vaccine of this type 
should be able effectively to interrupt the natural 
transmission of malaria; however, subjects effectively 
immunized against sporozoites will remain susceptible to 
challenge with asexual erythrocytic stages of the parasite 
(WHO. 1986). 
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The merozoite or an asexual erythrocytic-stage 
vaccine is expected to induce an immunity that operates by 
restricting the replication of asexual blood stage 
parasites without necessarily inducing sterile immunity. 
Consequently its function will be to reduce the morbidity 
and mortality due to malaria. However, persons immunized 
by this type of vaccine will remain susceptible to 
sporozoite infection and the parasites development in the 
liver will occur unimpeded; low grade asexual parasitaemia 
may occur and gametocytogenesis may evolve normally so that 
immunized persons would remain capable of infecting 
mosquitoes. It is unlikely that the asexual blood stage 
vaccines if used alone will achieve the interruption of 
malaria transmission in any endemic area; however they can 
be used in highly susceptible groups in endemic areas to 
induce a level of immunity which prevents serious illness 
after infection. The merozoite vaccine acts as a curative 
measure, and will overcome the problem of drug resistance. 
Irradiated parasitized erythrocytes have been extensively 
utilized as experimental immunogens. Some success was 
achieved with rodent malaria (Wellde and Sadun, 1967) in 
which irradiated erythrocytes infected with P. faJclEAriM 
were used to vaccinate owl monkeys (Wellde et a_i. . 1979). 
Two significant findings of these studies show that a 
degree of protection could be obtained without using an 
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adjuvant; and that four immunizinq doses were required to 
achieve significant degree of immunity. 
The third type of vaccine will operate by inducing in 
the human host serum antibodies that effectively block the 
fertilization of female gamete by male gametes v*ithin the 
mosquito gut, or inactivate the fertilized zygote or the 
ookinete. Such transmission blocking vaccines will 
apparently be capable of interrupting malaria transmission 
at the mosquito level, but will neither protect the human 
host against sporozoites, asexual blood stages, nor prevent 
the development of gametocytaemia. However, they are 
expected to reduce the overall rate of malaria transmission 
in endemic areas and thereby play an important role in 
control (WHO, 1986). The major prerequisite for producing 
a gamete vaccine is the availability of large number of 
infectious P. falci parum gametes and the continuous in 
vitro cultivation of P. falciparum has given great impetus 
for achieving this goal. 
The S-antigens of P. falciparum are the subject of 
great deal of research for vaccine production. Th.ey incucf 
significant protective immunity in Squirrel monkeys against. 
a virulent challenge by P. falciparum (Ristic e_t aj. • • 
1985). Shamansky e_t a_l. (1985) have purified two S-
23 
antigens (83 and 100 KDa) and have proposed that these may 
be good candidates for potential host protective antigens 
in malarial immunoprophylactic regimens. 
Development of successful malaria vaccines will 
depend on both the production of protective antigens by 
chemical synthesis or recombinant technology as well as the 
availability of safe and effective adjuvants. The best 
protection has been achieved only when monkeys were 
immunized in conjunction with Freund's complete adjuvant 
(FCA). 
Results of clinical trials with sporozoite and 
merozoite vaccines with alum as an adjuvant have shown 
limited immunogenicity and protective success. Since FCA 
is unacceptable for clinical use, as it has toxic side 
effects, and results of clinical trials with alum have 
shown limited success, as it shows humoral response but is 
deficient in inducing a ce11-mediated response; several 
laboratories have sought to establish a safe and effective 
adjuvant. Saponin has been found to be an effective 
adjuvant with rodent malaria antigen but its efficacy with 
purified or subunit human malaria antigens has yet to be 
studied. Based on knowledge generated on the immunology of 
malaria, it is evident that a malaria vaccine adjuvant must 
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be capable of inducing both humoral and cell mediated 
responses (Siddiqui, 1991a). 
The prospect for the development of effective malaria 
vaccines is reasonably good, but the realisation of this 
goal will require some time. Parasite antigenic diversity 
and genetic restrictions of immunological responses to 
these antigens in the human population pose great problems 
to the effectiveness of subunit malaria vaccines now beinn 
developed. 
Plasmodium knowlesi - THE SIMIAN MALARIA PARASITE 
The parasite is remarkable for its unique quotidian 
periodicity in the blood and it is almost 10051^  lethal in M. 
malatta: however in M. fasciculari s it is not lethal as the 
animal almost always survives the infection. The prepatant 
period is about 6 days and the animal soon becomes very ill 
as schizogony is rapid, resulting in rapid multiplication 
of the organisms. The animal becomes very weak 48 hours 
before death, for it refuses food, and has pallor of the 
skin and conjunctiva. There is high fever which becomes 
subnormal shortly before death (Garnham, 1980). 
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I n t r a v a s c u l a r h e m o l y s i s i s o f t e n p r e s e n t a long w i t h 
h a e m o g l o b i n u r i a . t h e p h e n o m e n o n o f e x c e s s i v e b l o o d 
d e s t r u c t i o n has been a t t r i b u t e d t o a u t o - i m m u n i z a t i o n 
(Zuckerman. 1966) . 
AIMS AND OBJECTIVES ^ 
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The present study aims to gheck the efficacy of P. 
knowlesi antigens for their use in serodiagnostic testa for 
human malaria. The role of serodiagnosis in malarial 
infections is indeed limited. At best it could be used as 
an adjunct to microscopic detection of parasites. Yet it 
would make things simpler if P. knowles i antigen, which 
can be easily obtained compared to antigens from human 
malarial parasites, could be used for identification of 
malaria specific human antibodies. Antigen pools from P. 
knowlesi could then be used for conducting large scale 
sero-epidemiological surveys in malaria endemic regions. 
Present investigations were, therefore, aimed to test 
the usefulness and the efficacy of P. knowlesi antigens in 
the identification of human malaria antibodies by means of 
indirect haemagglutination tests. If this antigen proves 
useful in IHA test then, hopefully, the antigen from monkey 
malaria can be usefully employed in several other 
diagnostic tests such as ELISA, RIA and several others. 
Slide smears with P. knowlesi infected monkey RBCs can also 
be effectively used for the detection of malaria specific 
human antibodies in IFA tests. Infact some preliminary 
tests along these lines have already been done in one or 
two other laboratories. 
11 
The Dresent investigations were therefore designed to 
achieve the above objective of using P. knowTesi antigen in 
IHA tests. The details of the experimental orotocols which 
were followed are as under: 
(1) P. knowlesi cell line was maintained in vivo using 
Rhesus monkeys as an animal model. 
(2) P. knowlesi antigen was isolated from the parasites 
harvested from the blood of infected Rhesus monkeys. 
(3) Serum samples were collected from clinically 
diagnosed malaria patients irrespective of their 
having a negative or a positive blood film. 
(4) Serum samples were collected from patients with no 
clinical evidence of malaria for the past five years 
and negative malaria blood films to serve as 
controls. 
( 5 ) Indirect haemagg1utination tests were performed on 
the serum samples using P. knowles i antigen for 
serodiagnosis of malaria. 
MATERIALS AND METHODS 
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ANIMALS 
Two young and healthy four month old Rhesus monkeys 
(Macaca mulatta) . a male and a female, each weighing about 
3-5 kgs were purchased from a local animal dealer. 
CELL-LINE 
PI asmod i urn K n o w l e s i c e l l l i n e was o b t a i n e d f r o m t h e 
M i c r o b i o l o g y D i v i s i o n o f t h e C e n t r a l D r u g R e s e a r c h 
I n s t i t u t e . L u c k n o w , I n d i a . 
ANTICOAGULANT 
A c i d c i t r a t e d e . x t r o s e was o b t a i n e d f r o m t h e B l o o d 
B a n k , J . N . M e d i c a l C o l l e g e , A l i g a r h . 
STAIN 
Leishman stain was purchased from BDH. England. 
CHEMICALS 
Sodium corbonate. sodium potassium tartarate. 
barbital, sodium barbitone, copper sulphate, disodium 
hydrogen phosphate, dihydrogen sodium phosphate and sodium 
chloride were obtained from BDH (India). Tannic acid was 
purchased from W.J. Bush and Co., England and Methanol from 
Merck (India). Bovine serum albumin and saponin were 
obtained from Sigma chemical Co., USA and chloroquine 
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injectible from IPCA Pvt. Ltd., Bombay Sheep red blood 
cells were obtained from healthy sheeps in the Central 
Animal House of the J.N. Medical College, Aligarh. 
Sodium azide, used as a preservative, was obtained 
from Rield, Germany. 
GLASSWARE 
A l l t h e g l asswa re used were o b t a i n e d f r o m Pyrex and 
Co .and C o r n i n g ( I n d i a ) L t d . The m i c r o t i t r e " U ' b o t t o m 
p l a t e s were f r om Cooke E n g i n e e r i n g C o . , A l e x a n d r i a . 
G l a s s d i s t i l l e d w a t e r was u s e d t h r o u g h o u t t h e 
e x p e r i m e n t and a s e p t i c c o n d i t i o n s m a i n t a i n e d w h e r e v e r 
n e c e s s a r y . 
SPECIMENS 
Five ml of blood was taken from 50 patients with 
clinically diagnosed malaria, who were attending the Out 
Patients Department, or from those patients who were 
admitted to the J.N. Medical College, Hospital Aligarh, 
India. 
The blood was drawn by a sterile syringe and needle 
(21G) and allowed to clot in a sterile universal bottle, or 
screw capped tube, which was later stored at 4*^ C overnight. 
The serum was obtained by centrifuging at 1,000 rpm for 30 
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minutes and stored in a sterile screw capped tuPe at -20°C 
for further use. 
Five ml of blood was also taken from 25 patients of 
the same age group with no clinical evidence of malaria for 
making malaria negative blood films to serve as controls. 
MAINTENANCE OF Plasmodium knowlesi CELL LINE 
The P. knowlesi cell line was maintained and allowed 
to multiply In v i vo in Rhesus monkeys which were 
inoculated, intravenously, with approximately 5.3 x 10 
parasitized monkey erythrocytes. After the appearance of 
parasites in the blood the parasitaemia reached B0% on the 
5th day of their appearance; the animals were bled at this 
stage and the blood collected in Acid Citrate Dextrose. 
Five ml of the infected blood sample was inoculated into a 
fresh animal, for subsequently maintaining the cell-line, 
while the rest was pooled for antigen isolation. Normal, 
uninfected monkeys were used as controls. 
COUNTING OF PARASITES 
Blood films were made every day by a finger prick to 
observe the appearance of the parasite after which they 
were used for counting the parasites. 
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STAINING AND FIXATION OF BLOOD FILMS 
Fixation of the dried blood films was done by 
using methanol for 4 minutes and the films dried again. 
The staining was carried by mixing equal volumes of 
Leishman stain and phosphate buffer (0.01 M, pH 7.2) and 
then layering this solution on the fixed and dried blood 
film for 30 minutes. The slides were then washed with 
phosphate buffer, air dried and examined under the oil 
immersion of a microscope (Carl Zeiss, Jena). 
ANTIGEN ISOLATION 
Parasites were harvested according to the procedure 
by Spira and Zuckerman (1962). At 80S$ parasitaemia blood 
was collected from the infected monkey in ACD by cardiac 
puncture under anaesthesia (Pentabarbitone sodium). The 
pooled cells were washed by centrifugation in chilled 
normal saline. The buffy coat containing leukocytes, 
plasma and platelets was discarded and the sediment with 
normal and parasitized erythrocytes pooled. The pooled 
erythrocytes were washed 4 times by centrifuging at 1500 
rpm for 10 minutes and incubated with an equal volume of 
saponin (0.05X in normal saline) with continuous stirring 
in an ice bath for 10 minutes. The lysate was centrifuged 
at 1500 rpm for 10 minutes at 4*^0, the supernatant 
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discarded and the pellet washed again 3-4 times with 
chilled normal saline to remove erythrocytes. After the 
final washing the pellet consisting of malaria parasite was 
suspended in chilled normal saline. 
PREPARATION OF WATER SOLUBLE WHOLE ANTIGEN 
The parasites were disrupted by ultrasonication of 
the parasite suspension in 3 stretches for 6 minutes 
altogether, in a 50 watt, 9 Kc magnetostriction oscillator. 
The suspension was centrifuged again at 1500 rpm for 20 
minutes and the supernatant collected was stored as soluble 
antigen, 
PROTEIN ESTIMATION 
Protein estimations were done according to Lowry ejt 
al . . (1951) using a Bausch and Lomb Spectronic 21 
Spectrophotometer at room temperature. 
MEASUREMENT OF pH 
The pH was measured by an Elico LI-120 pH meter using 
sodium tetraborate (0.1 M, pH 8.18) and Potassium hydrogen 
pthalate (0.05 M, pH 4.0) as standard buffers. 
INDIRECT HAEMAGGLUTINATION TEST (IHA) 
The IHA test was done according to the method 
described by Mathews §:t al-, (1975). 
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Sheep erythrocytes (SRBC) were washed 4 times with 
phosphate buffered saline (pH 7.2) after which a 0. 3S6 (v/v) 
suspension of the SRBC was prepared using PBS. The 
suspension was mixed with an equal volume of 1/20,000 
tannic acid and incubated at 4*^ 0 for 30 minutes with 
intermittent shaking. Tanned SRBC were washed thrice with 
PBS-BSA for the removal of free tannic acid and resuspended 
at 3%. A 0.1 ml tanned SRBC suspension was mixed with an 
equal volume of the diluted antigen and incubated at 37°C 
for 30 minutes with intermittent shaking. The antigen 
coated SRBC were washed 3 times with PBS-BSA and was used 
for making a ^ .5% suspension. 
An 0.025 ml of serially diluted serum sample was 
added to an equal volume of antigen coated SRBC suspension 
in a 'U' bottom microtitre plate. The control wells 
containing tanned RBC, normal sera and antigen were 
included in the test. The plates were incubated at room 
temperature in a humid chamber for 1 hour and then at 4°C 
overnight. The highest dilution of the test serum giving a 
positive carpet like pattern was recorded as the end point. 
Both positive and negative controls were used along 
with the test samples. 
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TREATMENT OF INFECTED ANIMALS 
5 mg/kg body weight of Chloroquine was injected to 
all experimentally infected monkeys before the animals 
reached the stage of maximum parasitaemia. 
RESULTS 
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Blood films made from peripheral blood of P. knowlesi 
infected Rhesus monkeys showed the presence of parasites on 
the 7th day following intravenous inoculation of 
parasitized monkey erythrocytes. The parasitaemia reached 
to a maximum count of about 80% on the 12th day. In the 
maximum diseased stage the animals became critically ill 
showing hyperthermia; these animals became weak, pale and 
refused all kinds of food. The animals were treated before 
they had maximum parasitaemia and the parasites were not 
seen in the peripheral blood after 2 days of treatment. 
Out of the 50 clinically diagnosed malaria patients 
21 (^2%) had a positive blood film and 29 (58%) had a 
negative blood film. When the IHA test was performed on 
the 50 clinically diagnosed patients, 17 (81%) out of 21 
blood film positive patients gave a positive IHA test and 
21 (73%) out of the 29 blood film negative patients gave a 
positive IHA test (Tableil). The 25 normal control 
patients, which were all blood film negative, showed a 
positive IHA test in only 1 (4%) patient (Table:II). 
The 50 malaria patients consisted of 23 males and 27 
females: the total number of blood smear positive were 14 
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(67X) and 7 (33%) f o r ma les and f e m a l e s r e s p e c t i v e l y 
f T a b l e : I I I ) . 
Of t h e 21 s l i d e p o s i t i v e p a t i e n t s 18 (865K) we re 
i n f e c t e d w i t h P. v i v a x and 3 (14%) were i n f e c t e d w i t h 
P. f a l c i p a r u m ( T a b l e : I V ) . 
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Table I: Seropositivity of malaria antibodies in clinically 
diagnosed malaria patients using indirect haemagglutination 
test (IHA) 
GROUPS TOTAL NUMBER TOTAL NUMBER PERCENTAGE 











Total 50 38 76 
FIGURE 1: SEROPOSITIVITY OF MALARIA 
SPECIFIC ANTIBODIES BY IHA TESTS IN THE 





Total number of blood film positive cases. 
Total number of IHA oositlve cases in the blood 
film positive group. 
Total number of blood film negative cases. 
Total number of IHA positive cases in the blood 
film negative group. 
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Table II: Seropositivity of malaria antibodies in normal 
control patients using IHA test 
GROUP TOTAL NUMBER TOTAL NUMBER PERCENTAGE 




Table III: Sex distribution of s l i d e p o s i t i v e m a l a r i a 
patients 
SEX TOTAL NUMBER TOTAL NUMBER OF PERCENTAGE 
SLIDE POSITIVE 
Male 23 14 6 7 
Female 27 7 33 
TOTAL 50 21 42 
FIGURE 2 : Photograph of Indirect Haemagglutination 
test 
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Table IV: Distribution of Plasmodium vivax and Plasmodium 
falciparum in slide positive malaria patients 
TOTAL NUMBER NUMBER OF NUMBER OF 
POSITIVE P. vivax P. falciparum 
21 18 3 
PERCENTAGE 86 14 
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FIGURE 4: DISTRIBUTION OF P. VIVAX AND 








Table V: Distribution of IHA titres in malaria patients 
GROUPS TOTAL TOTAL INDIRECT HAEMAGGLUTINATION TITRES 
NUMBER NUMBER 
TESTED POSITIVE < 16 16-64 128-512 > 1024 
(> 16) 
Blood Smear 21 17 4 6 10 1 
Positive 
Blood Smear 29 21 8 13 8 0 
Negative 
Control 25 1 24 1 0 0 
FIGURE 6: FREQUENCY OF IHA TITRES 
IN MALARIA CASES AND CONTROL 
) 1024 
C. IHA t i t res in blood film negative cases. 
B. IHA t i t res in blood film positive cases. 
A. THA t i t res in Controls. 
DISCUSSION AND CONCLUSION 
47 
Until some time back the only source of malaria 
parasites was the infected host; however, the development 
of continuous j_n vitro culture of P. falciparum has lead to 
a large-scale production of infected blood stages in vitro. 
Malaria parasites have various degrees of host 
specificity and pathogenicity which affect the level of 
parasitaemia obtained in any species. The degree of 
infection with a given parasite may be affected by factors 
such as age, sex and genetic strain of the host (Zuckerman 
and Yoeli, 1954; Eling et al. , 1977; Miller 1976). Blood 
collected from infected animals or humans which is to be 
used for harvesting Plasmodia, may be subjected to certain 
preliminary treatments to remove unwanted blood components 
and to increase the proportion of parasitized erythrocytes. 
Plasma is removed by centrifugation and washing, the buffy 
coat is removed from the packed red cell mass to reduce the 
number of platelets and leukocytes (Zuckerman et, al . . 
1967). Leukocytes may be removed by suspending the washed 
blood cells in several volumes of dextran solution or 
obtaining them as supernatant on sedimentation (Zuckerman 
et aj.. , 1967, Langer et aj.. , 1967). Sedimentation velocity 
of washed blood cells on dextran (Levy and Chow, 1973) or 
on sucrose density gradient (Williamson and Cover, 1966) or 
on Ficol1-Hypaque solution which usually removes about 75^ 
leukocytes (Wallach and Conley, 1977). The slow speed 
centrifugation, which we used in our experiment, removes 
about 85* leukocytes. Homewood and Neame M976) reported 
that the most efficient procedure for removing leukocytes 
is the passage of diluted blood through a column of filter-
paper powder. 
P. knowlesi infection in the Rhesus monkey (Macaca 
mulatta) follows a characteristically rapid and fatal 
course resulting in the death of host by day 10 post-
inoculation (Dutta et al., 1981). While running a typical 
course of infection, it was revealed in differential 
parasite counts that the infection in Rhesus monkey is 
rather synchronous at a particular point and at this time 
the parasites mostly appear in the same stage of 
development (Khanna, 1984). 
Resurgence of malaria has currently made us realise 
the importance of developing some reliable serological 
tests. Serology is an important epidemiological tool along 
with blood slide examination, as malaria cannot always be 
detected by direct microscopic examination of blood film. 
Detection of antibody to malarial parasites can be useful 
in the diagnosis of clinical cases as well as screening for 
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disease c a r r i e r s , mainly in n o n - e n d e m i c a r e a s , and in 
epidemiological studies (Agarwal et aj.. , 1982; Biswas et. 
a1 •, 1990). The microscopic examination of blood slides is 
not the only parasitologic l a b o r a t o r y p r o c e d u r e used in 
malaria surveillance work to determine the occurrence of 
the disease. This method can only indicate the presence or 
absence of patent parasitaemia at the time of examination; 
it does not indicate the individual's malaria experience or 
the state of his immunity CKagan, 1972). 
Serologic tests are needed to detect infections in 
those cases in which the parasites in the peripheral blood 
are in such low numbers that they cannot be detected 
readily by parasitological examinations. We need serology 
to determine whether eradication measures have been 
successful, that is, whether transmission of malaria in 
endemic areas has been interrupted. Moreover, a proper 
surveillance needs to be maintained in those regions in 
which malaria has been successfully eradicated in order to 
prevent reintroduction of the parasite, which could bring 
about devastating epidemics in populations rendered 
susceptible by the absence of infection (Sadun, 1972). A 
practical serologic method for use in malaria programs must 
meet the following criteria, (a) the test has to be simple 
to perform; (D) the interpretation of results must be free 
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of subjectivity; (c) the test must be rapid; (d) the cost 
must be minimal; (e) the tests results have to be 
sufficiently sensitive and specific, and (f) the test must 
be capable of producing repeatedly reliable results in 
various laboratories. The indirect haemagglutination test 
meets these criteria better than other available serologic 
methods like indirect fluorescent antibody test and the 
complement fixation test (Kagan, 1972). 
The IHA test may have a wide range of applications in 
epidemiology. For example it may be used (1) to measure the 
level of malaria endemicity (Kagan et al. , 1969a); (2) to 
verify the absence or presence of transmission from a 
relatively small number of specimens (Mathews et. al . , 
1970a); (3) to delineate malarious areas (Mathews et al . . 
1970b); (4) to detect seasonal changes of malaria 
transmission (Kagan et aj.. , 1969b); (5) to investigate 
suspected reintroductions of malaria into consolidation or 
maintenance phase areas; and (6) to detect small foci of 
malaria transmission (Mathews ei al., 1970b). The test is 
especially useful in areas where the regular malaria 
surveillance work is limited, and it can be used 
effectively as a screening mechanism to detect potential 
carriers of malaria. 
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P. falciparum antigen obtained from infected Actus 
monkeys (Voller et al-, 1976; Mahajan, et al-, 1981), or 
from i_n vi tro cultures (Spencer e_t_ aj_.,1981) has been 
successfully used for diagnosis of malaria by the IHA test 
(Farshy and Kagan, 1972; Wilson ejt aj.. , 1975). Due to 
limitations in the availability of adequate amount of 
P. faici parum antigen in a sufficiently purified form, 
efforts are being made in several laboratories to evaluate 
the possibility of using P. knowlesi antigen for diagnosis 
of human malaria (Chandanani et aJ.-. 1981; Agarwal et al . . 
1981). This Plasmodium species was selected because Rhesus 
monkeys can be readily infected and can provide a large 
volume of parasitized red blood cells for obtaining antigen 
to be used for detection of P_. f al ci parum or P.. v i v a x 
infections (Kagan, 1972; Agarwal et al-, 1983). 
Our results show that 81% of the slide positive 
malaria patients obtained a significant antibody titre of 
2 1:16. This finding compares well with the of Agarwal et, 
al (1981, 1982) and Marwah et. aJ.. (1989); who also showed 
75%, 84.5% and 78% of significant antibody titres in slide 
positive malaria patients respectively. The slide negative 
patients showed a significant antibody titre in 73%, this 
seems to be in contrast to Marwah et, aj_ (1989) and Agarwal 
et al (1982) who showed 32% and 7.14% positive antibody 
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titres. The reason for this difference could be because 
most of the patients attending J.N. Medical College 
Hospital come from places in and around Aligarh which are 
at some distance from Aligarh and as such they do not come 
back again for slide parasitology; drugs are given to them 
on the basis of clinical symptoms of malaria irrespective 
of a negative laboratory diagnosis. The slides are 
generally made at a time when the parasites in the 
peripheral blood are in low numbers and as such the 
parasites are not easily detected. Differences in the 
method for preparations of P_. knowl es i antigen and the 
storage conditions may explain the low titres reported by 
Agarwal et al (1982) and Marwah et al (1989). 
The sera specimens from the 25 healthy control group 
were also subjected to IHA tests. Only 1 (4^) sample gave 
an antibody titre of >_ 1:16, this is in accordance with the 
results of Agarwal et aj. (1981; 1982) who showed positive 
IHA values in 4% and ^ . 5% respectively. A positive IHA 
result in 15.5* of normal healthy subjects has also been 
reported by Srivastava et aJ. (1983). 
In this study the sera were collected from 23 males 
and 27 females and out of these 61% males and 335^  females 
were found to have a positive blood film. Out of the 50 
slides made from the blood of clinically diagnosed malaria 
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patients only 21 slides showed malaria parasites giving a 
slide positivity rate of 42%: this is a little lower than 
that reoorted by Chowdhury ejt a_i (1983) who reported a 
slide positivity rate of 67.5%. This could be because the 
samples were collected from February to September and the 
highest incidence of malaria being from September to 
November only, and seemingly as such, the tip of the 
iceberg was reached (Chowdhury et al., 1983). 
Of the 21 slide positives 18 were of P. vivax and 3 
of P. f alci parum; this can be compared to the work of 
Marwah et al (1989) who also showed a higher incidence of 
P. vivax (94X). But these findings are in contrast with a 
study done in Senegal where P. falciparum was found to be 
the predominant species (Vercruysse et aj.. , 1983). 
Our results show that the IHA antibody titres of 
slide positive malaria patients ranged from l 1:16 
to 2 1:1024 with the highest number of positives having 
titres between 1:128 to 1:512. In the slide negative 
malaria patients most of the subjects having a positive IHA 
antibody titre ranged from 1:16 to 1:64 titre. The 4 of 
the slide positive sera gave a titre <_ 16, such a low titre 
could be attributed to the fact that IHA test is rather 
insensitive at detecting antibodies in the early phases of 
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primary infection. No slide negative patient had a 
titre >. 1024 (Marwah et al-. 1989). 
On the basis of this investigation and in the light 
of other similar studies it can be concluded that antigen 
prepared from £. knowlesi parasites can be successfully 
employed in the IHA test for detecting malaria specific 
human antibodies. An IHA positivity of 81% has been seen 
in the present study and this is in agreement with the 
results reported by other workers using heterologous 
ant i gen (Lobel e_t al . , 1973; Agarwal ejtaj.., 1981). 
Apparently, a high degree of specificity resides in the 
test as was evident from the very low positivity (4%) 
obtained among normal healthy controls. An IHA positivity 
of 73% in patients with slide negative malaria suggest that 
a small number of such persons may indeed be suffering from 
malaria. If serology is to be employed, as an adjunct to 
microscopic detection of parasites, the, the diagnosis of 
clinical cases of malaria on the basis of IHA antibody 
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